Olanzapine Versus Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Randomized Phase III Trial
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Oncology
Reference38 articles.
1. Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment;Bloechl-Daum;J Clin Oncol,2006
2. Pharmacological management of chemotherapy-induced nausea and vomiting: focus on recent developments;Navari;Drugs,2009
3. Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in patients with cancer;Navari;Future Oncol,2010
4. Aprepitant: a review of its use in the prevention of nausea and vomiting;Curran;Drugs,2009
5. Prevention of chemotherapy induced nausea and vomiting: a focus on aprepitant;Sankhala;Expert Opin Drug Metab Toxicol,2009
Cited by 266 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Experimental analysis and modeling of aprepitant (an antiemetic drug for chemotherapy) solubility in subcritical water with/without co-solvent;The Journal of Supercritical Fluids;2024-11
2. Preparation of Aprepitant nanoparticles using subcritical water anti-solvent technology;Powder Technology;2024-11
3. A randomized, double-blind, placebo-controlled phase II study of olanzapine based prophylactic antiemetic therapy for delayed and persistent nausea and vomiting in patients with HER2-positive or HER2-low breast cancer treated with trastuzumab deruxtecan: ERICA study (WJOG14320B);Annals of Oncology;2024-09
4. Effectivity of oral ginger supplementation for chemotherapy induced nausea and vomiting (CINV) in children: A systematic review of clinical trials;Journal of Ayurveda and Integrative Medicine;2024-07
5. Pharmacokinetics, pharmacodynamics, safety, and tolerability of dopamine-receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting;Expert Opinion on Drug Metabolism & Toxicology;2024-06-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3